Oramed Pharmaceuticals (ORMP)
(Delayed Data from NSDQ)
$2.54 USD
-0.04 (-1.55%)
Updated Jul 25, 2024 04:00 PM ET
After-Market: $2.54 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMIndustry / Sector Report
Industry : Medical - Products
Zacks Industry Rank
Top 39% (98 out of 250)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 3.00 | 1.69 | 9.99 |
Current Quarter Estimate | 0.01 | 5.41 | 61.00 |
Year Ago Quarter Estimate | -0.03 | -1.55 | 54.84 |
Next Quarter Estimate | 0.00 | 5.88 | 63.00 |
Next Year Estimate | -0.33 | 35.65 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 96.30 | 11.80 | 15.67 |
Next Year | -3,200.00 | 26.00 | 9.31 |
Last 5 Years | NA | 3.90 | 8.10 |
Next 5 Years | NA | 14.60 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -13.85 |
Price/Book (MRQ) | 0.63 | 2.09 |
Price/Cash Flow (MRFY) | NA | 11.19 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | 2.15% |
Return on Equity (TTM) | -3.83% | 13.47% |
Debt to Equity (MRQ) | NA | 17.49 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.